Literature DB >> 21584718

Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transport.

Matthew D Thompson1, Daniel A Beard.   

Abstract

Although the implementation of a flow-limited, well-stirred tank (WST) single-compartment tissue model in pharmacokinetics and toxicokinetics is widespread, its use is not always justified biophysically or physiologically. The WST model introduces a loss of biophysical detail, specifically the vascular space, which is present in the standard permeability-limited two-subcompartment (PLT) tissue model. To address this loss of detail when evaluating the in vivo kinetics of drugs, toxins, nutrients, and endogenous metabolites, a novel set of physiologically based pharmacokinetic tissue compartment equations is developed through application of an asymptotic approximation to a two-region vascular-extravascular system to arrive at a permeability-limited two-region asymptotically reduced (P-TAR) model and a flow-limited (F-TAR) model. Development of the TAR modeling approach illustrates the importance of relative timescales in PBPK tissue compartment model selection and the conditions under which improved biophysical realism is advantageous. In the permeability-limited regime, the TAR model formulations enable drug or toxicant concentration to be modeled in the vascular and extravascular spaces equivalent to the PLT tissue model while invoking only one state variable to represent the vascular and extravascular spaces. In the flow-limited regime, the F-TAR model is more biophysically realistic than the WST model because it maintains the anatomical distinction between the vascular and extravascular spaces, and hence offers greater pharmacological and physiological insight than the WST model, without introducing additional computational complexity.

Entities:  

Mesh:

Year:  2011        PMID: 21584718      PMCID: PMC3193163          DOI: 10.1007/s10928-011-9200-x

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  14 in total

1.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.

Authors:  Patrick Poulin; Frank-Peter Theil
Journal:  J Pharm Sci       Date:  2002-05       Impact factor: 3.534

2.  Modeling advection and diffusion of oxygen in complex vascular networks.

Authors:  D A Beard; J B Bassingthwaighte
Journal:  Ann Biomed Eng       Date:  2001-04       Impact factor: 3.934

Review 3.  Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.

Authors:  Frank-Peter Theil; Theodor W Guentert; Sami Haddad; Patrick Poulin
Journal:  Toxicol Lett       Date:  2003-02-18       Impact factor: 4.372

4.  GENTEX, a general multiscale model for in vivo tissue exchanges and intraorgan metabolism.

Authors:  James B Bassingthwaighte; Gary M Raymond; James D Ploger; Lisa M Schwartz; Thomas R Bukowski
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2006-06-15       Impact factor: 4.226

Review 5.  Physiological parameter values for physiologically based pharmacokinetic models.

Authors:  R P Brown; M D Delp; S L Lindstedt; L R Rhomberg; R P Beliles
Journal:  Toxicol Ind Health       Date:  1997 Jul-Aug       Impact factor: 2.273

6.  Capillary exchange modeling. Barrier-limited and flow-limited distribution.

Authors:  C A Goresky; W H Ziegler; G G Bach
Journal:  Circ Res       Date:  1970-11       Impact factor: 17.367

7.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

8.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

Review 9.  Theoretical models for drug delivery to solid tumors.

Authors:  A W el-Kareh; T W Secomb
Journal:  Crit Rev Biomed Eng       Date:  1997

Review 10.  Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.

Authors:  Chad M Thompson; Douglas O Johns; Babasaheb Sonawane; Hugh A Barton; Dale Hattis; Robert Tardif; Kannan Krishnan
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2009-01       Impact factor: 6.393

View more
  15 in total

1.  Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes.

Authors:  Carrie German; Minu Pilvankar; Andrzej Przekwas
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-08-08       Impact factor: 2.745

2.  Comparison of distributed and compartmental models of drug disposition: assessment of tissue uptake kinetics.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-08-17       Impact factor: 2.745

3.  Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.

Authors:  Matthew D Thompson; Daniel A Beard
Journal:  J Pharm Sci       Date:  2011-10-03       Impact factor: 3.534

4.  Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.

Authors:  Matthew D Thompson; Daniel A Beard; Fan Wu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-26       Impact factor: 2.745

5.  PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.

Authors:  Frédéric Y Bois; Cleo Tebby; Céline Brochot
Journal:  Methods Mol Biol       Date:  2022

6.  Consideration of Fractional Distribution Parameter fd in the Chen and Gross Method for Tissue-to-Plasma Partition Coefficients: Comparison of Several Methods.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharm Res       Date:  2022-03-14       Impact factor: 4.580

7.  Engineering challenges for instrumenting and controlling integrated organ-on-chip systems.

Authors:  John P Wikswo; Frank E Block; David E Cliffel; Cody R Goodwin; Christina C Marasco; Dmitry A Markov; David L McLean; John A McLean; Jennifer R McKenzie; Ronald S Reiserer; Philip C Samson; David K Schaffer; Kevin T Seale; Stacy D Sherrod
Journal:  IEEE Trans Biomed Eng       Date:  2013-02-01       Impact factor: 4.538

8.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

9.  Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats.

Authors:  Mihye Kwon; Jung Bae Park; Miwha Kwon; Jinho Song; Chang Su Yeo; Soo Hyeon Bae
Journal:  Arch Toxicol       Date:  2021-04-12       Impact factor: 5.153

Review 10.  Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.

Authors:  Wells Utembe; Harvey Clewell; Natasha Sanabria; Philip Doganis; Mary Gulumian
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.